Avacta Group (LON:AVCT) Trading Down 13.2% – Time to Sell?

Avacta Group Plc (LON:AVCT)’s share price traded down 13.2% during mid-day trading on Tuesday . The stock traded as low as GBX 33 ($0.42) and last traded at GBX 33 ($0.42). 2,673,765 shares changed hands during mid-day trading, an increase of 96% from the average session volume of 1,364,946 shares. The stock had previously closed at GBX 38 ($0.48).

Avacta Group Stock Down 13.2 %

The firm’s fifty day moving average price is GBX 47.33 and its 200-day moving average price is GBX 53.41. The company has a debt-to-equity ratio of 52.53, a current ratio of 1.29 and a quick ratio of 4.96. The firm has a market capitalization of £125.37 million, a P/E ratio of -4.25 and a beta of 1.12.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).